Side-by-side analyses of research compounds that are often studied or discussed together, comparing mechanisms of action, published evidence, and reported study findings. These articles clarify how similar peptides differ, where their research overlaps, and what the current literature does and does not establish about each.
How RAD-140 and LGD-4033 compare on mechanism, trial findings, suppression and liver signals, and the regulatory and quality issues that surround SARMs.
Five growth hormone compounds, each with a different mechanism. We compare CJC-1295, Ipamorelin, GHRP-6, Tesamorelin, and MK-677 side by side on potency, side effects, and research status.
Both are recovery peptides, but they work through completely different mechanisms. We compare TB-500 and BPC-157 on healing speed, tissue types, and what the animal studies show.
Three receptors versus two. We compare the mechanisms, trial results, and potential advantages of retatrutide over tirzepatide based on the data available so far.
Two popular growth hormone peptides with very different release patterns. We compare how they stimulate GH, their half-lives, and what researchers have learned about using them.
The two biggest weight loss drugs go head to head. We break down the clinical trial numbers, side effect profiles, and mechanisms to show where each one actually wins.
Join our newsletter for weekly peptide research updates, new study summaries, and exclusive content delivered to your inbox.
